Correlation Between Dyadic International and Halozyme Therapeutics

Can any of the company-specific risk be diversified away by investing in both Dyadic International and Halozyme Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Halozyme Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dyadic International and Halozyme Therapeutics, you can compare the effects of market volatilities on Dyadic International and Halozyme Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Halozyme Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Halozyme Therapeutics.

Diversification Opportunities for Dyadic International and Halozyme Therapeutics

-0.53

Correlation Coefficient

Dyadic International  Halozyme Therapeutics

Excellent diversification

The 3 months correlation between Dyadic and Halozyme is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Halozyme Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Halozyme Therapeutics and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Halozyme Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Halozyme Therapeutics has no effect on the direction of Dyadic International i.e., Dyadic International and Halozyme Therapeutics go up and down completely randomly.

Pair Corralation between Dyadic International and Halozyme Therapeutics

Given the investment horizon of 90 days Dyadic International is expected to generate 1.53 times more return on investment than Halozyme Therapeutics. However, Dyadic International is 1.53 times more volatile than Halozyme Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Halozyme Therapeutics is currently generating about -0.1 per unit of risk. If you would invest  124.00  in Dyadic International on September 13, 2024 and sell it today you would earn a total of  41.00  from holding Dyadic International or generate 33.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Dyadic International  vs.  Halozyme Therapeutics

Dyadic International

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dyadic International are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, Dyadic International demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Halozyme Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Halozyme Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Dyadic International and Halozyme Therapeutics

The main advantage of trading using opposite Dyadic International and Halozyme Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Halozyme Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Halozyme Therapeutics will offset losses from the drop in Halozyme Therapeutics' long position.

The idea behind Dyadic International and Halozyme Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.